Neurological manifestations and implications of COVID-19 pandemic.
Authors
Tsivgoulis, GeorgiosPalaiodimou, Lina
Katsanos, Aristeidis H
Caso, Valeria
Köhrmann, Martin
Molina, Carlos
Cordonnier, Charlotte
Fischer, Urs
Kelly, Peter
Sharma, Vijay K
Chan, Amanda C
Zand, Ramin
Sarraj, Amrou
Schellinger, Peter D
Voumvourakis, Konstantinos I
Grigoriadis, Nikolaos
Alexandrov, Andrei V
Tsiodras, Sotirios
Issue Date
2020-06-09Keywords
COVID-19SARS-CoV-2
cerebrovascular diseases
healthcare impact
neurological manifestations
Metadata
Show full item recordJournal
Therapeutic advances in neurological disordersDOI
10.1177/1756286420932036PubMed ID
32565914Abstract
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China and rapidly spread worldwide, with a vast majority of confirmed cases presenting with respiratory symptoms. Potential neurological manifestations and their pathophysiological mechanisms have not been thoroughly established. In this narrative review, we sought to present the neurological manifestations associated with coronavirus disease 2019 (COVID-19). Case reports, case series, editorials, reviews, case-control and cohort studies were evaluated, and relevant information was abstracted. Various reports of neurological manifestations of previous coronavirus epidemics provide a roadmap regarding potential neurological complications of COVID-19, due to many shared characteristics between these viruses and SARS-CoV-2. Studies from the current pandemic are accumulating and report COVID-19 patients presenting with dizziness, headache, myalgias, hypogeusia and hyposmia, but also with more serious manifestations including polyneuropathy, myositis, cerebrovascular diseases, encephalitis and encephalopathy. However, discrimination between causal relationship and incidental comorbidity is often difficult. Severe COVID-19 shares common risk factors with cerebrovascular diseases, and it is currently unclear whether the infection per se represents an independent stroke risk factor. Regardless of any direct or indirect neurological manifestations, the COVID-19 pandemic has a huge impact on the management of neurological patients, whether infected or not. In particular, the majority of stroke services worldwide have been negatively influenced in terms of care delivery and fear to access healthcare services. The effect on healthcare quality in the field of other neurological diseases is additionally evaluated.Item Type
ArticleOther
Language
enISSN
1756-2856ae974a485f413a2113503eed53cd6c53
10.1177/1756286420932036
Scopus Count
Collections
Related articles
- Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
- Authors: Maury A, Lyoubi A, Peiffer-Smadja N, de Broucker T, Meppiel E
- Issue date: 2021 Jan-Feb
- Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
- Authors: Harapan BN, Yoo HJ
- Issue date: 2021 Sep
- Neurological Sequelae of COVID-19.
- Authors: Ahmad SJ, Feigen CM, Vazquez JP, Kobets AJ, Altschul DJ
- Issue date: 2022 Apr 6
- Environmental Issues and Neurological Manifestations Associated with COVID-19 Pandemic: New Aspects of the Disease?
- Authors: Bellocchio L, Bordea IR, Ballini A, Lorusso F, Hazballa D, Isacco CG, Malcangi G, Inchingolo AD, Dipalma G, Inchingolo F, Piscitelli P, Logroscino G, Miani A
- Issue date: 2020 Nov 1
- Neurological manifestations and complications of COVID-19: A literature review.
- Authors: Ahmad I, Rathore FA
- Issue date: 2020 Jul